295 related articles for article (PubMed ID: 23478163)
1. Oropharyngeal cancers: significance of HPV16 detection in neck lymph nodes.
Mirghani H; Ferchiou M; Moreau F; Vourexakis Z; Amen F; Breuskin I; Lefèvre M; Casiraghi O; Drusch F; Soussan P; Vielh P; St Guily JL
J Clin Virol; 2013 Jun; 57(2):120-4. PubMed ID: 23478163
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases.
Mirghani H; Moreau F; Lefèvre M; Tam C; Périé S; Soussan P; St Guily JL
Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):910-4. PubMed ID: 21930979
[TBL] [Abstract][Full Text] [Related]
3. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma.
Weiss D; Koopmann M; Rudack C
Head Neck; 2011 Jun; 33(6):856-62. PubMed ID: 20737490
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
[No Abstract] [Full Text] [Related]
7. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma metastatic to neck from an unknown primary: the potential impact of modern pathologic evaluation on perceived incidence of human papillomavirus-positive oropharyngeal carcinoma prior to 1970.
Chenevert J; Seethala RR; Barnes EL; Chiosea SI
Laryngoscope; 2012 Apr; 122(4):793-6. PubMed ID: 22252715
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer.
Hashida Y; Higuchi T; Matsumoto S; Iguchi M; Murakami I; Hyodo M; Daibata M
Cancer Sci; 2021 Oct; 112(10):4404-4417. PubMed ID: 34382311
[TBL] [Abstract][Full Text] [Related]
10. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
Begum S; Gillison ML; Nicol TL; Westra WH
Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
[TBL] [Abstract][Full Text] [Related]
11. Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16.
Biesaga B; Mucha-Małecka A; Janecka-Widła A; Kołodziej-Rzepa M; Szostek S; Słonina D; Kowalczyk A; Halaszka K; Przewoźnik M
J Cancer Res Clin Oncol; 2018 Jan; 144(1):63-73. PubMed ID: 29043437
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
Faust H; Eldenhed Alwan E; Roslin A; Wennerberg J; Forslund O
J Gen Virol; 2016 Nov; 97(11):2949-2956. PubMed ID: 27667722
[TBL] [Abstract][Full Text] [Related]
13. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
14. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
[TBL] [Abstract][Full Text] [Related]
15. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
[TBL] [Abstract][Full Text] [Related]
16. HPV detection and genotyping of head and neck cancer biopsies by molecular testing with regard to the new oropharyngeal squamous cell carcinoma classification based on HPV status.
Veyer D; Wack M; Grard O; Bonfils P; Hans S; Bélec L; Badoual C; Péré H
Pathology; 2019 Jun; 51(4):421-425. PubMed ID: 31005250
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
18. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
[TBL] [Abstract][Full Text] [Related]
19. HPV16 DNA in histologically confirmed tumour-free neck lymph nodes of head and neck cancers.
Hoffmann M; Orlamünder A; Sucher J; Gottschlich S; Görögh T; Fazel A; Ambrosch P; Rittgen W; Schwarz E; Kahn T
Anticancer Res; 2006; 26(1B):663-70. PubMed ID: 16739336
[TBL] [Abstract][Full Text] [Related]
20. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
